Singapore markets close in 36 minutes
Straits Times Index
3,286.07 +20.12 (+0.62%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,422.96 +41.61 (+0.50%) Bitcoin USD
62,970.61 +1,622.21 (+2.64%) CMC Crypto 200
1,305.18 -52.83 (-3.89%)
Argent BioPharma Limited (MGCLF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 10:34AM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 11.34M |
| Enterprise value | 7.37M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.11 |
| Price/book (mrq) | 13.11 |
| Enterprise value/revenue | 4.42 |
| Enterprise value/EBITDA | -0.48 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.97 |
| 52-week change 3 | -95.44% |
| S&P500 52-week change 3 | 26.43% |
| 52-week high 3 | 6.9000 |
| 52-week low 3 | 0.2250 |
| 50-day moving average 3 | 0.2792 |
| 200-day moving average 3 | 0.7165 |
Share statistics
| Avg vol (3-month) 3 | 249 |
| Avg vol (10-day) 3 | 135 |
| Shares outstanding 5 | 45.28M |
| Implied shares outstanding 6 | 45.56M |
| Float 8 | 21.35M |
| % held by insiders 1 | 7.90% |
| % held by institutions 1 | 1.20% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:1000 |
| Last split date 3 | 30 Oct 2023 |
Financial highlights
Currency in AUD.Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,343.42% |
Management effectiveness
| Return on assets (ttm) | -58.96% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 1.32M |
| Revenue per share (ttm) | 0.10 |
| Quarterly revenue growth (yoy) | -77.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -14.44M |
| Net income avi to common (ttm) | -17.02M |
| Diluted EPS (ttm) | -2.1100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 6.48M |
| Total cash per share (mrq) | 0.18 |
| Total debt (mrq) | 9.65M |
| Total debt/equity (mrq) | 1,436.12% |
| Current ratio (mrq) | 0.75 |
| Book value per share (mrq) | 0.04 |
Cash flow statement
| Operating cash flow (ttm) | -13.14M |
| Levered free cash flow (ttm) | -6.57M |
© 2024 Yahoo. All rights reserved.